DrugPatentWatch Database Preview
Taro Pharms Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for TARO PHARMS, and what generic alternatives to TARO PHARMS drugs are available?
TARO PHARMS has fourteen approved drugs.
There are four US patents protecting TARO PHARMS drugs.
There are twenty-five patent family members on TARO PHARMS drugs in thirteen countries and twenty-nine supplementary protection certificates in eleven countries.
Summary for Taro Pharms
| International Patents: | 25 |
| US Patents: | 4 |
| Tradenames: | 12 |
| Ingredients: | 12 |
| NDAs: | 14 |
Drugs and US Patents for Taro Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro Pharms | MICONAZOLE NITRATE | miconazole nitrate | CREAM;VAGINAL | 074444-001 | Jan 13, 1997 | OTC | No | No | Start Trial | Start Trial | |||||
| Taro Pharms | TRETINOIN | tretinoin | CREAM;TOPICAL | 211644-001 | Jan 25, 2019 | AB1 | RX | No | No | Start Trial | Start Trial | ||||
| Taro Pharms | NAFTIFINE HYDROCHLORIDE | naftifine hydrochloride | CREAM;TOPICAL | 206901-001 | Jan 6, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Taro Pharms | DAPSONE | dapsone | GEL;TOPICAL | 210191-001 | Jun 26, 2019 | DISCN | No | No | Start Trial | Start Trial | |||||
| Taro Pharms | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | AT | RX | Yes | Yes | 8,277,780 | Start Trial | Y | Start Trial | ||
| Taro Pharms | TAZAROTENE | tazarotene | CREAM;TOPICAL | 208258-001 | Apr 3, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Taro Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Taro Pharms | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 5,919,479 | Start Trial |
| Taro Pharms | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | 5,990,100 | Start Trial |
| Taro Pharms | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 6,528,086 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for TARO PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
International Patents for Taro Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2609579 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2011088333 | Start Trial |
| European Patent Office | 1702597 | Start Trial |
| Denmark | 1244401 | Start Trial |
| Japan | 2003510259 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2006130510 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Taro Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1304992 | PA2013025 | Lithuania | Start Trial | PRODUCT NAME: CLINFAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323 |
| 1458369 | 122008000041 | Germany | Start Trial | PRODUCT NAME: ADAPALEN IN KOMBINATION MIT BENZOYLPEROXID; NAT. REGISTRATION NO/DATE: 67913.00.00 20080229; FIRST REGISTRATION: DAENEMARK 40440 20071218 |
| 0526708 | C300097 | Netherlands | Start Trial | PRODUCT NAME: BOSENTAN, DESGEWENST IN DE VORM VAN EEN ZOUT OF EEN HYDRAAT OF IN DE VORM VAN EEN ESTER VAN DE HYDROXYLGROEP VAN DE 2-HYDROXYETHOXY REST MET EEN ZUUR MET DE FORMULE R5-OH, WAARIN R5 EEN C1-7-ALKANOYL, BENZOYL, OF HETEROCYCLYCARBONYL VOORSTELT; NATL. REGISTRATION NO/DATE: U/1/02/220/001 - 005 20020515; FIRST REGISTRATION: CH IKS 58841 01 - 02 20020228 |
| 1586316 | 122011100019 | Germany | Start Trial | PRODUCT NAME: BROMFENAC (2-AMINO-3-(4-BROMOBENZOYL)PHENYLESSIGSAEURE); REGISTRATION NO/DATE: EU/1/11/692/001 20110518 |
| 1458369 | C01458369/01 | Switzerland | Start Trial | PRODUCT NAME: ADAPALENUM + BENZOYLIS PEROXIDUM; REGISTRATION NUMBER/DATE: SWISSMEDIC 58460 19.05.2009 |
| 0284288 | 12/1998 | Austria | Start Trial | PRODUCT NAME: TAZAROTENE; NAT. REGISTRATION NO/DATE: 1-22102, 1-22103 19970918; FIRST REGISTRATION: DE 37393.00.00, 37393.01.00 19961203 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
